Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) EPS (Basic): 2012-2025

Historic EPS (Basic) for Veracyte (VCYT) over the last 13 years, with Sep 2025 value amounting to $0.24.

  • Veracyte's EPS (Basic) rose 20.00% to $0.24 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.39, marking a year-over-year increase of 400.00%. This contributed to the annual value of $0.32 for FY2024, which is 131.37% up from last year.
  • As of Q3 2025, Veracyte's EPS (Basic) stood at $0.24, which was up 2,500.00% from -$0.01 recorded in Q2 2025.
  • In the past 5 years, Veracyte's EPS (Basic) ranged from a high of $0.24 in Q3 2025 and a low of -$0.66 during Q1 2021.
  • For the 3-year period, Veracyte's EPS (Basic) averaged around -$0.03, with its median value being -$0.01 (2025).
  • Per our database at Business Quant, Veracyte's EPS (Basic) crashed by 660.00% in 2023 and then spiked by 550.00% in 2025.
  • Veracyte's EPS (Basic) (Quarterly) stood at -$0.14 in 2021, then surged by 64.29% to -$0.05 in 2022, then plummeted by 660.00% to -$0.38 in 2023, then skyrocketed by 118.42% to $0.07 in 2024, then climbed by 20.00% to $0.24 in 2025.
  • Its EPS (Basic) was $0.24 in Q3 2025, compared to -$0.01 in Q2 2025 and $0.09 in Q1 2025.